$
0. 25
0
0%
$
36.43M Market Cap
- P/E Ratio
- Div Yield
4,000 Volume
- Eps
$ 0.25
Previous Close Want to track MDNAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 10 months ago
